In this week’s episode, Fred Goldstein and I discuss transformative technologies from the 2 Nobel Prize winners in Chemistry this year, Emmanuelle Charpentier and Jennifer A. Doudna “for the development of a method for genome editing” – aka CRISPR. A technology that is revolutionizing medicine in general but also part of another initiative to detect […]
This week I discuss the potential for a second wave of infection and what that could mean for businesses trying to re-open and how your testing strategy can contribute to the opening without creating a second wave. Should you do clinical screening, viral or antibody testing, and which strategies should be applied. One of the […]
Screening for Businesses This week I discuss the challenges of screening and how companies and businesses need to approach this area. How you screen, who you screen and what screening are complex issues that are dependent on your specific business its risk profile, your employee risk profiles and of course what the latest science is on the virus There […]
Celebrating a Life with Zoom I attended a Zoom Celebration of Life of a friend who died recently and while it was imperfect it was an adaptation necessary in the current circumstances, we find ourselves in especially as Funerals and weddings which are one of several examples of activities that are higher risk gatherings for […]
